| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $909.4M | +0.5% | +33.9% |
| Cost of Revenue | $621.2M | +1.4% | +41.7% |
| Gross Profit | $288.1M | -1.6% | +19.6% |
| R&D Expense | $29.3M | +8.9% | +45.8% |
| SG&A Expense | $82.7M | -2.2% | +17.2% |
| Operating Income | $176.1M | -2.9% | +17.2% |
| Pre-tax Income | $180.5M | -1.2% | +12.7% |
| Income Tax | $49.3M | +37.4% | +15.0% |
| Net Income | $131.2M | -10.6% | +13.8% |
| EPS (Basic) | $0.88 | -11.1% | +10.0% |
| EPS (Diluted) | $0.85 | -12.4% | +7.6% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $952.6M | +12.7% | +37.4% |
| Accounts Receivable | $452.2M | -17.7% | -1.2% |
| Inventory | $275.3M | +24.5% | +26.7% |
| Current Assets | $2.56B | +5.0% | +28.3% |
| Total Assets | $3.80B | +3.6% | +27.4% |
| Current Liabilities | $1.08B |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $391.5M | — | — |
| Capital Expenditures | $31.5M | — | — |
| Investing Cash Flow | -$158.3M | — | — |
| Financing Cash Flow | -$46.6M | — | — |
| Free Cash Flow | $360.0M | — | — |
| +19.9% |
| Total Liabilities | $1.65B | -2.0% | +5.8% |
| Stockholders' Equity | $2.15B | +8.3% | +52.9% |